SPY411.49+2.97 0.73%
DIA337.86+2.73 0.81%
IXIC13,900.19+70.88 0.51%

European Medicines Agency: Benefits of AstraZeneca vaccine continue to outweigh the risks

· 03/16/2021 09:16
European Medicines Agency: Benefits of AstraZeneca vaccine continue to outweigh the risks

- Europe's medicines watchdog on Tuesday said the benefits of AstraZeneca's AZN.L COVID-19 vaccine continue to outweigh the risks after several countries halted its use due to concerns about blood clots.

The EMA's Executive Director Emer Cooke said the agency was carrying out a case-by-case evaluation of incidents and was expected to complete a review on Thursday.


(Reporting by Anthony Deutsch; Editing by Catherine Evans)

((anthony.deutsch@thomsonreuters.com;))